Tuan Zea Tan
Tuan Zea Tan
Cancer Science Institute of Singapore
Verified email at nus.edu.sg
Title
Cited by
Cited by
Year
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery
EMBO molecular medicine 6 (10), 1279-1293, 2014
3322014
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …
RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...
Cell death & disease 4 (11), e915-e915, 2013
2412013
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell–mediated lysis
I Akalay, B Janji, M Hasmim, MZ Noman, F André, P De Cremoux, ...
Cancer research 73 (8), 2418-2427, 2013
2132013
Dual role of autophagy in hallmarks of cancer
SS Singh, S Vats, AYQ Chia, TZ Tan, S Deng, MS Ong, F Arfuso, CT Yap, ...
Oncogene 37 (9), 1142-1158, 2018
1502018
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
1442013
Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
A Ng, S Tan, G Singh, P Rizk, Y Swathi, TZ Tan, RYJ Huang, ...
Nature cell biology 16 (8), 745-757, 2014
1352014
A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure
TZ Tan, C Quek, GS Ng, EYK Ng
Expert Systems with Applications 33 (3), 652-666, 2007
1262007
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
BL Khoo, SC Lee, P Kumar, TZ Tan, ME Warkiani, SGW Ow, S Nandi, ...
Oncotarget 6 (17), 15578, 2015
1002015
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
EM Shin, HS Hay, MH Lee, JN Goh, TZ Tan, YP Sen, SW Lim, EM Yousef, ...
The Journal of clinical investigation 124 (9), 3807-3824, 2014
972014
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway
M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ...
Cell death & disease 5 (7), e1346-e1346, 2014
892014
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori
Oncogene 34 (15), 1899-1907, 2015
872015
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
MZ Noman, B Janji, A Abdou, M Hasmim, S Terry, TZ Tan, ...
Oncoimmunology 6 (1), e1263412, 2017
812017
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification
VY Chung, TZ Tan, M Tan, MK Wong, KT Kuay, Z Yang, J Ye, J Muller, ...
Scientific reports 6 (1), 1-15, 2016
772016
Molecular characterization of breast cancer CTCs associated with brain metastasis
D Boral, M Vishnoi, HN Liu, W Yin, ML Sprouse, A Scamardo, DS Hong, ...
Nature communications 8 (1), 1-10, 2017
712017
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects
CQ Wang, V Krishnan, LS Tay, DWL Chin, CP Koh, JY Chooi, GSS Nah, ...
Cell reports 8 (3), 767-782, 2014
692014
Ovarian cancer diagnosis with complementary learning fuzzy neural network
TZ Tan, C Quek, GS Ng, K Razvi
Artificial intelligence in medicine 43 (3), 207-222, 2008
642008
Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors
TZ Tan, M Rouanne, KT Tan, RYJ Huang, JP Thiery
European urology 75 (3), 423-432, 2019
612019
Brain-inspired genetic complementary learning for stock market prediction
TZ Tan, C Quek, GS Ng
2005 IEEE Congress on Evolutionary Computation 3, 2653-2660, 2005
612005
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
A Datta, SY Loo, B Huang, L Wong, SSL Tan, TZ Tan, SC Lee, JP Thiery, ...
Oncotarget 5 (15), 5920, 2014
602014
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer
J Antony, TZ Tan, Z Kelly, J Low, M Choolani, C Recchi, H Gabra, ...
Science Signaling 9 (448), ra97-ra97, 2016
592016
The system can't perform the operation now. Try again later.
Articles 1–20